fda semaglutide mash GLP-1 BREAKTHROUGH: APPROVES TREATMENT FOR SERIOUS LIVER DISEASE Semaglutide, a medication already known for its role in weight management, is now the first GLP-1 therapy approved to treat (Metabolic Dysfunction–Associated Exciting Phase 3 Data from

doi:10.1089/acm.2008.0539

Key Takeaways A recent NAD decision underscores that advertising compounded drugs in a way that implies they share the benefits of FDA-approved medications will likely be deemed deceptive by regulators

If your RA medications are doing something but not enough, and your flares and fatigue keep coming back, there may be a metabolic piece of your puzzle no one has addressed yet

L-Carnitine is a naturally occurring amino acid derivative that plays a critical role in energy metabolism

GSH reduced form An increased GSSG-to-GSH ratio is considered indicative of oxidative stress

She uses bioelectrical impedance analysis to track fat loss versus muscle loss a distinction she said is critical to getting results from the medication